Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Valproate in Dementia (VALID)

ClinicalTrials.gov ID: NCT00071721

Public ClinicalTrials.gov record NCT00071721. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 12:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Trial of Valproate to Attenuate the Progression of Alzheimer's Disease (AD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to demonstrate whether valproate therapy delays the emergence of agitation and/or psychosis in outpatients with probable Alzheimer's disease (AD) who have not experienced agitation and psychosis in their illness. A secondary aim is to determine whether valproate therapy delays the progression of cognitive and functional measures of the illness. This trial will also assess the tolerability and safety of low-dose, long-term valproate therapy. Valproate, an anticonvulsant drug, was selected because of its possible symptomatic efficacy for agitation in AD, known safety profile in numerous clinical populations, and in view of recent data supporting its neuroprotective potential in AD.

Study identification

NCT ID
NCT00071721
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
313 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2003 (Type not available)
Primary completion
Feb 2009 (Actual)
Completion
Dec 2009 (Actual)
Last update posted
Sep 25, 2014

2003 – 2009

United States locations

U.S. sites
46
U.S. states
22
U.S. cities
41
Facility City State ZIP Site status
Sun Health Research Institute Sun City Arizona 85351 —
University of Arizona Tucson Arizona 85724 —
University of California, Irvine Irvine California 92697-4540 —
University of California, ADRC, San Diego La Jolla California 92093-0624 —
VA Healthcare System Long Beach Long Beach California 90822 —
University of Southern California Los Angeles California 90089-0191 —
University of California ADRC Los Angeles California 90095-1769 —
University of California, LA (Olive View) Los Angeles California 90095 —
Pacific Research Network San Diego California 32103 —
Stanford University, VA Aging Clinical Research Center Stanford California 94304 —
Yale University School of Medicine New Haven Connecticut 06511 —
Georgetown University Medical Center Washington D.C. District of Columbia 20057 —
Howard University Washington D.C. District of Columbia 20060 —
Mayo Clinic Jacksonville Florida 32224 —
Wein Center, Mount Sinai Medical Center Miami Florida 33140 —
University of South Florida Tampa Florida 33617 —
Byrd Institute Tampa Florida 33647 —
Premier Research Institute West Palm Beach Florida 33407 —
Emory University Atlanta Georgia 30329 —
Northwestern University Chicago Illinois 60611 —
Southern Illinois University Springfield Illinois 62794 —
Indiana University School of Medicine Indianapolis Indiana 46202-5120 —
University of Kansas Kansas City Kansas 66160 —
Lahey Clinic, Research Neurology Burlington Massachusetts 01805 —
University of Michigan Ann Arbor Michigan 48109-0489 —
Saint Mary's Health Care Grand Rapids Michigan 49503 —
St. Louis University St Louis Missouri 63103 —
University of Nevada Las Vegas Nevada 89154-5084 —
Albany Medical Center Albany New York 12208 —
Dent Neurologic Institute Amherst New York 14226 —
New York University Medical Center New York New York 10016 —
Columbia University New York New York 10032 —
Global Research and Consulting Olean New York 14760 —
University of Rochester Rochester New York 14642 —
Syracuse VA Medical Center Syracuse New York 13210 —
North East Ohio Health Services Beachwood Ohio 44122 —
Case Western Reserve University, University Hospitals of Cleveland Cleveland Ohio 44120 —
University of Pennsylvania Philadelphia Pennsylvania 19104-4283 —
Brown University, Memorial Hospital of Rhode Island Providence Rhode Island 02860 —
Medical University of South Carolina-Columbia Columbia South Carolina 29203 —
Medical University of South Carolina-Florence Florence South Carolina 29502 —
Medical University of South Carolina North Charleston South Carolina 29406-6076 —
Psychiatric Consultants Nashville Tennessee 37203 —
University of Texas Southwestern Medical Center Dallas Texas 75390-9070 —
Southwestern Vermont Medical Center Bennington Vermont 05201 —
University of Virginia Charlottesville Virginia 22908 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00071721, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 25, 2014 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00071721 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →